Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
  1. S-4 Deal Registration Statement - Business Combination
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. S-3 Offering Registration Statement
  6. 10-Q/A Report 10-Q/A
  7. SC 13D Stake Beneficial Ownership Report
  8. 10-Q Report Quarterly Report
  9. DEF 14A Proxy Proxy Statement
  10. 10-K/A Report 10-K/A
  11. 10-K Report Annual Report
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13D Stake Beneficial Ownership Report
  14. 10-Q Report Quarterly Report
  15. 8-K Event Item 5 · Item 7
  16. 10-Q Report Quarterly Report
  17. 10-Q Report Quarterly Report
  18. DEF 14A Proxy Proxy Statement
  19. 10-K Report Annual Report
  20. 10-Q Report Quarterly Report

Page 64 of 65 · 1,298 filings